Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
peter_juni [2022/05/15 01:21]
liam [Studies and Publications] | peter_juni [2022/08/05 04:09] (current)
liam [Abbott Laboratories] |
|---|
| ==== Abbott Laboratories ==== | ==== Abbott Laboratories ==== |
| |
| Jüni serves as an unpaid member of the steering group or executive committee of trials funded by [[Abbott]] Vascular and [[St. Jude Medical]], which was acquired by Abbott Laboratories in January 2017.((Cortez, M. F. (2016, April 28). //Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion.// Bloomberg. https://www.bloomberg.com/news/articles/2016-04-28/abbott-agrees-to-buy-st-jude-medical-for-25-billion)) ((Wang, D. (2016, April 28). //Abbott-St. Jude Combination: Why It Makes Sense.// Bloomberg Daybreak: Americas. https://www.bloomberg.com/news/videos/2016-04-28/abbott-st-jude-combination-why-it-makes-sense)) | Jüni serves as an unpaid member of the steering group or executive committee of trials funded by [[Abbott]] Vascular and [[St. Jude Medical]], which was acquired by Abbott Laboratories in January 2017.((Cortez, M. F. (2016, April 28). //Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion.// Bloomberg. https://www.bloomberg.com/news/articles/2016-04-28/abbott-agrees-to-buy-st-jude-medical-for-25-billion)) ((Wang, D. (2016, April 28). //Abbott-St. Jude Combination: Why It Makes Sense.// Bloomberg Daybreak: Americas. https://www.bloomberg.com/news/videos/2016-04-28/abbott-st-jude-combination-why-it-makes-sense)) ((Jüni, P. (2021, October 4). //ICMJE Disclosure Form.// BMJ. https://web.archive.org/web/20220805012030/https://www.bmj.com/sites/default/files/attachments/bmj-article/pre-pub-history/coi_disclosure_pj_rapid.pdf)) |
| |
| ==== Amgen ==== | ==== Amgen ==== |
